A new way to produce hyperketonemia: Use of ketone ester in a case of Alzheimer's disease

Alzheimer's and Dementia

Volumn 11, Issue 1, 2015, Pages 99-103

  Newport, Mary T ^a   Vanitallie, Theodore B ^b   Kashiwaya, Yoshihiro ^c   King, Michael Todd ^d   Veech, Richard L ^d  

^a Spring Hill Neonatology Inc   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^c Tominaga Hospital   (Japan)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Brain insulin resistance; Fasting; Ketogenic diet; Ketone bodies; Ketone monoester; Medium chain triglyceride; Pyruvate dehydrogenase; Hydroxybutyrate

Indexed keywords

3 HYDROXYBUTYRIC ACID; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; COCONUT OIL; CREATINE KINASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KETONE BODY; KETONE MONOESTER; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDIUM CHAIN FATTY ACID; MEDIUM CHAIN TRIACYLGLYCEROL; SEMAGACESTAT; TAU PROTEIN; UNCLASSIFIED DRUG; (R)-3-HYDROXYBUTYL (R)-3-HYDROXYBUTYRATE; GLUCOSE; HYDROXYBUTYRIC ACID;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AFFECT; ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE; AMNESIA; ARTICLE; BLISTER; CASE REPORT; CHOLESTEROL BLOOD LEVEL; COGNITION; DAILY LIFE ACTIVITY; DEPRESSION; ENERGY METABOLISM; FAINTNESS; FEVER; GAIT; HUMAN; HYPERKETONEMIA; KETOGENIC DIET; LOW CARBOHYDRATE DIET; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; MOOD; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECALL; RESPIRATORY TRACT INFECTION; SELF CARE; SHORT TERM MEMORY; SOCIAL PARTICIPATION; VERBAL MEMORY; WOUND HEALING; BLOOD; CHEMICALLY INDUCED; DEFICIENCY; DIETARY SUPPLEMENT; KETOACIDOSIS; METABOLISM;

3-HYDROXYBUTYRIC ACID; ALZHEIMER DISEASE; DIETARY SUPPLEMENTS; GLUCOSE; HUMANS; HYDROXYBUTYRATES; KETONE BODIES; KETOSIS; MALE; MIDDLE AGED;

EID: 84922709891     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2014.01.006     Document Type: Article

References (23)

1. Cunnane S, Nugent S, Roy M, Courchesne-Loyer A, Croteau E, Tremblay S, et al. Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition 2011;27:3-20.
2. De La Monte SM. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res 2012;9:35-66.
3. Mosconi L, Berti V, McHugh P, Pupi A, De Leon MJ. A tale of two tracers: glucose metabolism and amyloid positron emission tomography imaging in Alzheimer's disease. In: Ashford JW, et al., eds. Handbook of imaging the Alzheimer brain. Amsterdam: IOS Press; 2011. p. 219-34.
4. Talbot K, Wang H-Y, Kazi H, Han LY, Bakshi KP, Stucky A, et al. Demonstrated brain insulin resistance in Alzheimer's disease is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012;122:1316-38.
5. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr. Brain metabolism during fasting. J Clin Invest 1967;46:1589-95.
6. Vanltallie TB, Nufert TH. Ketones: metabolism's ugly duckling. Nutr Rev 2003;61:327-41.
7. Courchesne-Loyer A, Fortier M, Tremblay-Mercier J, Chouinard-Watkins R, Roy M, Nugent S, et al. Stimulation of mild, sustained ketonemia by medium-chain triacylglycerols in healthy humans: estimated potential contribution to brain energy metabolism. Nutrition 2013;29:635-40.
8. Denton RM, Randle PJ, Bridges BJ, Cooper RH, Kerbey AL, Pask HT, et al. Regulation of mammalian pyruvate dehydrogenase. Mol Cell Biochem 1975;9:27-53.
9. Kim VI, Lee FN, Choi WS, Lee S, Youn JH. Insulin regulation of skeletal muscle PDK4 mRNA expression is impaired in acute insulinresistant states. Diabetes 2006;55:2311-7.
10. Blomqvist G, Alvarsson M, Grill V, Von Heijne G, Ingvar M, Thorell JO, et al. Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. Am J Physiol Endocrinol Metab 2002;283:E20-8.
11. Kossoff EH, Freeman J, Turner Z, Rubenstein J. Ketogenic diets: treatments for epilepsy and other disorders. 5th edition. New York: Demos; 2011. p. 1-341.
12. Henderson ST, Vogel JL, Barr L, Garvin F, Jones JJ, Costantini LG. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab 2009;6:31. http://dx.doi.org/10.1186/1743-7075-6-31.
13. Krikorian R, Shidler MD, Dangelo K, Couch SC, Benoit SC, Clegg DJ. Dietary ketosis enhances memory in mild cognitive impairment. Neurobiol Aging 2012;33:425. e19-27. http://dx.doi.org/10.1016/j.neurobiolaging. 2010.10.006.
14. Clarke K, Tchabanenko K, Pawlosky R, Carter E, King MT, Musa-Veloso K, et al. Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul Toxicol Pharmacol 2012;63:401-8.
15. Clarke K, Tchabanenko K, Pawlosky R, Carter E, Knight NS, Murray AJ, et al. Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate. Regul Toxicol Pharmacol 2012;63:196-208.
16. Kashiwaya Y, Bergman C, Lee J-H, Wan R, King MT, Mughal MR, et al. A ketone ester diet exhibits anxiolytic and cognitive-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease. Neurobiol Aging 2012. Pii: S0197-4580 (12) 00611-2. doi: 10.1016/j.neurobiolaging.2012.11.023. [Epub ahead of print].
17. Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, et al. Effects of b-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging 2004;25:311-4.
18. Tate B, McKee TD, Loureiro RM, Dumin JA, Xia W, Pojasek K, et al. Modulation of gamma-secretase for the treatment of Alzheimer's disease. Int J Alzheimers Dis 2012;2012:210756. http://dx.doi.org/10.1155/2012/210756. Epub December 19, 2012.
19. Veech RL, Chance B, Kashiwaya Y, Lardy HA, Cahill GF Jr. Ketone bodies, potential therapeutic uses. IUBMB Life 2001;51:241-7.
20. Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 2004;70:309-19.
21. Kerndt PR, Naughton JL. Fasting: the history, pathophysiology and complications. West J Med 1982;137:379-99.
22. Lecocq FE, McPhaul FR Jr. The effects of starvation, high fat diets, and ketone infusions on uric acid balance. Metabolism 1965;14:186-97.
23. Vining EP. Clinical efficacy of the ketogenic diet. Epilepsy Res 1999;37:181-90.